Peter S. LaViolette

39 posts

Peter S. LaViolette

Peter S. LaViolette

@LaviolettePeter

เข้าร่วม Ekim 2016
215 กำลังติดตาม112 ผู้ติดตาม
Peter S. LaViolette
Peter S. LaViolette@LaviolettePeter·
Tosa in the dark right now, we’re near Sendik’s on North Ave. drone video starts facing magnetic North. #tosarocks
English
1
0
1
99
Peter S. LaViolette รีทวีตแล้ว
Jen Connelly
Jen Connelly@JenConnellyMD·
Thanks to the Laviolette Lab for representing Neuro-oncology and the brain tumor bank at the MCW Brain Expo today! @LaviolettePeter @brain_expo @NeurologyMCW
Jen Connelly tweet media
English
1
4
16
794
Peter S. LaViolette รีทวีตแล้ว
Neurology MCW
Neurology MCW@NeurologyMCW·
MCW BrainExpo is Sat., 3/11, 9am - 6pm. A free, fun event in MKE where people of all ages and backgrounds learn about the brain through presentations and interactive exhibits. Talks at 11am, 1pm, and 3pm. Free parking. @NeuroscienceMCW @CTSIWI @brain_expo #neuroscience
Neurology MCW tweet media
English
0
4
10
958
Peter S. LaViolette รีทวีตแล้ว
Froedtert
Froedtert@Froedtert·
This educational seminar about issues men with prostate cancer experience takes place Oct. 1 and registration is required. Learn more on our events page. froedtert.com/classes-events…
English
0
2
1
0
Peter S. LaViolette รีทวีตแล้ว
ISMRM
ISMRM@ISMRM·
The abstract and stipend application has been EXTENDED for the ISMRM Workshop on Cancer Imaging: From Discovery to Diagnosis! Submit yours by 19 September 2022: bit.ly/3Bo55v2
ISMRM tweet media
English
0
4
4
0
Peter S. LaViolette รีทวีตแล้ว
Virginia Hill, MD
Virginia Hill, MD@virginiabhill·
Samuel Bobholz and @LaviolettePeter present maps showing phenotypes of #GBM that correlate with survival and bevacizumab treatment response. Great work.
Virginia Hill, MD tweet mediaVirginia Hill, MD tweet media
English
1
2
4
0
Peter S. LaViolette รีทวีตแล้ว
Cancer Study Group ISMRM
Cancer Study Group ISMRM@ISMRM_Cancer·
Our first Tweet. Well, not so many people follow us. Want to give a retweet and help us to make this account to be a good communication tool for our study group and share with you the progress of our colleagues in the world of cancer diagnosis, detection and prevention? .@ISMRM
English
0
18
29
0